The Global Smart Inhalers Market is Expected to Foresee Significant Growth. North America to Lead the Growth!

Global smart inhalers market is expected to register a CAGR of ~16% over the period of 2022-2028. A smart inhaler device is a biosensor-laden inhaler with extra digital features. The embedded biosensor is linked to an app on a phone or tablet to help patients and doctors manage their asthma and COPD better. They’re all designed to automatically track how often a patient is using an inhaler, so the patient doesn’t need to keep records. The wireless data transmission, real-time feedback, and alerting mechanism are some of the common features that are incorporated inside a smart inhaler device. Several factors such as the accelerating geriatric population, increasing prevalence of respiratory disorders, growing air pollution, and greater penetration of smartphones and the internet are driving the growth of the market. For instance, according to World Health Organization (WHO), the number of people aged 65 and above is projected to grow from 524 million in 2010 to nearly 1.5 billion in 2050 with the maximum increase in developing countries. A smart inhaler integrates with mobile phones using sensors and Bluetooth technology to track daily usage and alert patients when missed a dosage. The mobile app may also provide insights into health that may be shared with the doctor. The technology is believed to increase medication adherence which in turn decreases severe flare-ups and emergency hospitalizations. Therefore, the market is expected to grow during the forecasted period.

For a detailed analysis of the Global Smart Inhalers Market browse through – https://univdatos.com/report/smart-inhalers-market-2/

Based on the product, the smart inhalers market is segmented into inhalers and nebulizers. The inhalers segment accounted for a significant market share in 2021 and is estimated to grow rapidly during the projected timeframe. Studies revealed that due to a patient’s error in drug intake, which occurs approximately 70% to 90% of the time, results in 7% to 40% of the drug being delivered to the lungs. An error in the coordination between inhalation and release of drugs is commonly observed error among patients. Improper inhalation technique creates decreased efficacy through reduced deposition of drugs in the lungs, eventually leading to an increase in the need for the use of advanced and smart inhalers. Also, they are Bluetooth-enabled and can be paired wirelessly with a smart device like a phone or tablet or with a computer to allow data to be transferred from the smart inhaler automatically, thereby leading to the growth of the segment.

Based on the end-users, the market is fragmented into hospitals & clinics, respiratory care centers, and others. The hospitals & clinics segment grabbed a considerable market share and is expected to grow at a significant CAGR during the forecast period. The prevalence of respiratory diseases such as asthma and COPD is plunging the adoption of smart inhalers in hospitals and clinics. Digital technologies hold promises to overcome the barriers to care. Improvement in inhalers and the arrival of newer technology is creating an upsurge in the demand for this efficient technology in the hospital & clinics segment.

Request for sample of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=5285

For a better understanding of the market adoption of smart inhalers, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., Spain, France, Italy, and the Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and the Rest of Asia-Pacific), and Rest of World. North America constitutes a major market for the smart inhalers industry owing to the improving healthcare facilities and services driving the development and adoption of more advanced technologies in North America. An increase in respiratory disorders and pollution will lead to the escalation in chronic disorders such as asthma and COPD, which are some of the major drivers of innovation that will lead to the growth of the market in North America.

Some of the major players operating in the smart inhalers market are Boehringer Ingelheim, Cohero Health, Inc., Omron Corporation, Novartis, AstraZeneca, Teva Pharmaceuticals Industries Ltd., Vectura Group, GlaxoSmithKline, Adherium Limited, 3M among others. Several M&A’s along with partnerships have been undertaken by these players.

Global Smart Inhalers Market Segmentation

Market Insight, by Product

· Inhalers

o Dry Powder Inhaler (DP)

o Metered Dose Inhaler (MDI)

· Nebulizers

Market Insight, by Indication

· Chronic Obstructive Pulmonary Disease (COPD)

· Asthma

Market Insight, by Distribution Channel

· Hospital Pharmacies

· Retail Pharmacies

· Online Channel

Market Insight, by End-User

· Hospitals & Clinics

· Respiratory Care Centre

· Others

Market Insight, by Region

· North America

o U.S.

o Canada

o Rest of North America

· Europe

o Germany

o U.K.

o Spain

o France

o Italy

o Rest of Europe

· Asia-Pacific

o China

o India

o Japan

o Australia

o South Korea

o Rest of Asia-Pacific

· Rest of World

Top Company Profiles

· Boehringer Ingelheim

· Cohero Health, Inc.

· Omron Corporation

· Novartis

· AstraZeneca

· Teva Pharmaceuticals Industries Ltd.

· Vectura Group

· GlaxoSmithKline

· Adherium Limited

· 3M